cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Pliant Therapeutics Inc
4 own
5 watching
Current Price
$31.74
$-0.54
(-1.67%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
1,547.32M
52-Week High
52-Week High
36.64
52-Week Low
52-Week Low
3.965
Average Volume
Average Volume
0.46M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization1,547.32M
icon52-Week High36.64
icon52-Week Low3.965
iconAverage Volume0.46M
iconDividend Yield--
iconP/E Ratio--
What does the Pliant Therapeutics Inc do?
Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a trials. The company also develops PLN-1474, a small-molecule selective inhibitor of avß1, which completed Phase 1 clinical trial for the treatment of liver fibrosis associated with nonalcoholic steatohepatitis. In addition, it is developing two additional preclinical integrin-based programs, which include an oncology program, as well as a program for an allosteric agonistic monoclonal antibody against an undisclosed integrin receptor for treatment of muscular dystrophies, including duchenne muscular dystrophy. Pliant Therapeutics, Inc. was incorporated in 2015 and is based in South San Francisco, California.
Read More
How much money does Pliant Therapeutics Inc make?
News & Events about Pliant Therapeutics Inc.
Globe Newswire
2days ago
SOUTH SAN FRANCISCO, Calif., Feb. 07, 2023 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX), a clinical stage biotechnology company focused on discovering and developing novel therapeutics for the treatment of fibrosis, today announced senior managements participation in the following ...
Globe Newswire
7days ago
Phase 1 clinical study initiation expected in the second quarter of 2023SOUTH SAN FRANCISCO, Calif., Feb. 02, 2023 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX), a clinical stage biotechnology company focused on discovering and developing novel therapeutics for the treatment of ...
MarketBeat - AP News
15days ago
Pliant Therapeutics zoomed 34% higher and added to that gain in the next session.This followed good news about clinical trials for a lung-condition treatment...
Globe Newswire
15days ago
SOUTH SAN FRANCISCO, Calif., Jan. 24, 2023 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc.(Nasdaq: PLRX), a clinical stage biotechnology company focused on discovering anddeveloping novel therapeutics for the treatment of fibrosis, today announced the pricing of an upsized underwritten public offering...
Globe Newswire
15days ago
SOUTH SAN FRANCISCO, Calif., Jan. 25, 2023 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX), a clinical stage biotechnology company focused on discovering and developing novel therapeutics for the treatment of fibrosis, today announced Ms. Lily Cheung as its Chief Human Resources Officer...
Frequently Asked Questions
Frequently Asked Questions
What is Pliant Therapeutics Inc share price today?
plus_minus_icon
Can Indians buy Pliant Therapeutics Inc shares?
plus_minus_icon
How can I buy Pliant Therapeutics Inc shares from India?
plus_minus_icon
Can Fractional shares of Pliant Therapeutics Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Pliant Therapeutics Inc stocks?
plus_minus_icon
What is today’s traded volume of Pliant Therapeutics Inc?
plus_minus_icon
What is today’s market capitalisation of Pliant Therapeutics Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Pliant Therapeutics Inc?
plus_minus_icon
What percentage is Pliant Therapeutics Inc down from its 52-Week High?
plus_minus_icon
What percentage is Pliant Therapeutics Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$31.74
$-0.54
(-1.67%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00